Page last updated: 2024-11-06

hexobendine and Vertigo

hexobendine has been researched along with Vertigo in 1 studies

Hexobendine: A potent vasoactive agent that dilates cerebral and coronary arteries, but slightly constricts femoral arteries, without any effects on heart rate, blood pressure or cardiac output.

Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wessely, P1

Trials

1 trial available for hexobendine and Vertigo

ArticleYear
[Therapy of the post-commotion syndrome].
    Wiener medizinische Wochenschrift (1946), 1976, Mar-05, Volume: 126, Issue:10

    Topics: Benzamides; Brain Concussion; Drug Combinations; Drug Evaluation; Headache; Hexobendine; Humans; Nau

1976